Pfizer
PFE
PFE
1,968 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 755 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% more capital invested
Capital invested by funds: $140B → $146B (+$6.18B)
5% less funds holding in top 10
Funds holding in top 10: 267 → 253 (-14)
39% less call options, than puts
Call options by funds: $1.79B | Put options by funds: $2.95B
Holders
1,968
Holding in Top 10
253
Calls
$1.79B
Puts
$2.95B
Top Buyers
| 1 | +$604M | |
| 2 | +$445M | |
| 3 | +$422M | |
| 4 |
CM
Corvex Management
New York
|
+$401M |
| 5 |
Sanders Capital
West Palm Beach,
Florida
|
+$340M |
Top Sellers
| 1 | -$1.47B | |
| 2 | -$1.43B | |
| 3 | -$695M | |
| 4 |
Bank of New York Mellon
New York
|
-$378M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$200M |